Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Spontaneous Urticaria (CSU)”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Not applicableLooking for participantsNCT07328178
What this trial is testing

Analysis of the Role of IgE Proteoforms in Health and Disease

Who this might be right for
AnaphylaxisMastocytosisX-linked Agammaglobulinaemia+6 more
KU Leuven 200
Large-scale testing (Phase 3)Study completedNCT00757562
What this trial is testing

Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Who this might be right for
Chronic Idiopathic UrticariaAtopy
Organon and Co 97
Large-scale testing (Phase 3)Study completedNCT05795153
What this trial is testing

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 144
Testing effectiveness (Phase 2)Ended earlyNCT05528861
What this trial is testing

Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Allakos Inc. 127
Large-scale testing (Phase 3)Study completedNCT05526521
What this trial is testing

Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 15
Not applicableLooking for participantsNCT07316114
What this trial is testing

Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 400
Large-scale testing (Phase 3)Study completedNCT01803763
What this trial is testing

Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients

Who this might be right for
Chronic UrticariaChronic Idiopathic UrticariaChronic Spontaneous Urticaria
Insel Gruppe AG, University Hospital Bern 30
Testing effectiveness (Phase 2)Ended earlyNCT06555328
What this trial is testing

Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

Who this might be right for
Chronic Urticaria, IdiopathicHidradenitisHidradenitis Suppurativa
InflaRx GmbH 73
Large-scale testing (Phase 3)Study completedNCT04976192
What this trial is testing

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Urticaria
Teva Pharmaceuticals USA 608
Testing effectiveness (Phase 2)Study completedNCT01713725
What this trial is testing

Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria

Who this might be right for
Chronic Urticaria
Clinica Universidad de Navarra, Universidad de Navarra 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06162728
What this trial is testing

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria
Jasper Therapeutics, Inc. 88
Large-scale testing (Phase 3)UnknownNCT04944602
What this trial is testing

Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 340
Not applicableAvailableNCT05170724
What this trial is testing

Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Early research (Phase 1)UnknownNCT04175704
What this trial is testing

Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
United BioPharma 32
Testing effectiveness (Phase 2)Study completedNCT00866788
What this trial is testing

Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)

Who this might be right for
Chronic Idiopathic Urticaria
Genentech, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT01081574
What this trial is testing

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Who this might be right for
Allergic RhinoconjunctivitisChronic Urticaria
Faes Farma, S.A. 36
Large-scale testing (Phase 3)Study completedNCT00795158
What this trial is testing

How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)

Who this might be right for
Urticaria
Organon and Co 282
Large-scale testing (Phase 3)Study completedNCT01723072
What this trial is testing

Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy

Who this might be right for
Chronic Spontaneous UrticariaAngioedema
Novartis Pharmaceuticals 91
Post-approval studies (Phase 4)Study completedNCT00795522
What this trial is testing

An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)

Who this might be right for
Urticaria
Organon and Co 51
Testing effectiveness (Phase 2)Study completedNCT05107115
What this trial is testing

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 161
Load More Results